ALT: Altimmune, Inc. Stock

by  •  • Comments Off on ALT: Altimmune, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 440.41
Enterprise Value ($M) 391.31
Book Value ($M) 142.16
Book Value / Share 1.75
Price / Book 3.08
NCAV ($M) 140.16
NCAV / Share 1.73
Price / NCAV 3.12

Profitability (mra)
Return on Invested Capital (ROIC) -0.63
Return on Assets (ROA) -0.48
Return on Equity (ROE) -0.52

Liquidity (mrq)
Quick Ratio 15.85
Current Ratio 15.85

Balance Sheet (mrq) ($M)
Current Assets 155.26
Assets 157.26
Liabilities 15.10
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.02
Operating Income -103.17
Net Income -95.06
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -79.85
Cash from Investing -28.39
Cash from Financing 10.04

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-15 13G/A Ameriprise Financial Inc 1.90 -72.52
02-05 13G/A BlackRock, Inc. 8.70 52.28
10-17 13G/A State Street Corp 4.80 -12.67
10-16 13G/A Millennium Management Llc 0.20 -95.05

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-02-27 10-K 2024 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-30 692,240 2,265,056 30.56
2025-05-29 304,932 1,338,957 22.77
2025-05-28 412,789 1,263,893 32.66
2025-05-27 613,154 2,239,348 27.38

(click for more detail)

Similar Companies
ACIU – AC Immune SA ACRV – Acrivon Therapeutics, Inc.
ADMA – ADMA Biologics, Inc. ANIP – ANI Pharmaceuticals, Inc.
APGE – Apogee Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io